Author:
Kato Satoshi,Sato Kozo,Sato Takeshi,Gen Motoyoshi,Miyakoshi Naohisa
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology,Orthopedics and Sports Medicine,General Medicine,Endocrinology, Diabetes and Metabolism
Reference19 articles.
1. Koshihara Y, Hoshi K, Shiraki M (1992) Enhancement of mineralization of human osteoblasts by vitamin K2 (menaquinone 4) (in Japanese). Igaku no Ayumi (J Clin Exp Med) 161:439–440
2. Hauschka PV, Reid ML (1978) Vitamin K dependence of a calcium-binding protein containing γ-carboxyglutamic acid in chicken bone. J Biol Chem 253:9063–9068
3. Hara K, Akiyama Y, Tajima T, Shiraki M (1993) Menatetrenone inhibits bone resorption partly through inhibition of PGE2 synthesis in vitro. J Bone Miner Res 8:535–542
4. Koshihara Y, Hoshi K, Shiraki M (1993) Vitamin K2 (menatetrenone) inhibits prostaglandin synthesis in cultured human osteoblast-like periosteal cells by inhibiting prostaglandin H synthase acvitity. Biochem Pharmacol 46:1355–1362
5. Trechsel U, Stutzer A, Fleisch H (1987) Hypercalcemia induced with an arotinoid in thyroparathyroidectomized rats: new model to study bone resorption in vivo. J Clin Invest 80:1679–1686